logo
Plus   Neg
Share
Email

Belden Slashes FY19 Outlook - Quick Facts

While reporting financial results for the second quarter, Belden Inc. (BDC) on Wednesday slashed its adjusted earnings guidance for the full year 2019 as it expects a more challenging demand environment in its Industrial markets in the second half. The company also initiated guidance for the third quarter.

For fiscal 2019, the company slashed adjusted earnings guidance to a range of $5.38 to $5.78 per share from the prior guidance range of $5.65 to $6.15 per share.

Revenues for the full year are also now expected between $2.485 billion and $2.535 billion, down from the prior guidance range of $2.520 billion to $2.595 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.86 per share on revenues of $2.54 billion for the year. Analysts' estimates typically exclude special items.

The company also projects third-quarter adjusted earnings in a range of $1.32 to $1.52 per share and revenues between $620 million and $645 million. Street is looking for earnings of $1.57 per share on revenues of $647.93 million for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT